Key facts
- Airotone’s last known valuation is $25.2M (Mar 2025).
- It has raised $5.2M across 1 recorded rounds; the latest was Early Stage VC ($5.2M) in Mar 2025.
- Notable investors include Serial Stage Venture Partners.
- Airotone has filed 1 Form D with the SEC, most recently Mar 2025 ($5.2M sold to 35 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Airotone
Funding rounds
1 roundsAbout Airotone
Developer of respiratory therapy devices designed for easier breathing. The company offers interactive, affordable strength trainers, OPEP airway clearance devices, spirometers, and advanced inhaler technologies, enabling patients to improve their quality of life for patients living with chronic respiratory conditions.
- Sector
- Healthcare
- HQ
- Naples, FL, United States
- Founded
- 2021
- Employees
- 15
- Website
- airotone.com/
- Ownership
- Privately Held (backing)
Airotone doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Airotone shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Airotone in its N-PORT filings yet. We sweep new filings monthly.